EFFECTS OF SAMPLE HANDLING ON THE STABILITY OF INTERLEUKIN 6, TUMOUR NECROSIS FACTOR-α AND LEPTIN

Considine, 1996, Leptin: genes, concepts and clinical perspective, Horm Res, 46, 249, 10.1159/000185096

Mohamed-Ali, 1998, Adipose tissue as an endocrine and paracrine organ, Int J Obes Relat Metab Disord, 22, 1145, 10.1038/sj.ijo.0800770

Rock, 1996, The leptin haemopoietic cytokine fold is stabilized by an intrachain disulfide bond, Horm Metab Res, 28, 649, 10.1055/s-2007-979871

Somers, 1997, 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling, EMBO J, 16, 989, 10.1093/emboj/16.5.989

Eck, 1989, The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding, J Biol Chem, 264, 17595, 10.1016/S0021-9258(18)71533-0

Heinrich, 1990, Interleukin-6 and the acute phase response, Biochem J, 265, 621, 10.1042/bj2650621

Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance, J Clin Invest, 95, 409, 10.1172/JCI117936

Yudkin, 2000, Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?, Atherosclerosis, 148, 209, 10.1016/S0021-9150(99)00463-3

Kroemer, 1993, Immunoregulation by cytokines, Crit Rev Immunol, 13, 163

Mohamed-Ali, 1997, Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo, J Clin Endocrinol Metab, 82, 4196

Pinkney, 1998, Effect of isoprenaline on plasma leptin and lipolysis in humans, Clin Endocrinol Oxf, 48, 407, 10.1046/j.1365-2265.1998.00480.x